Caribou Biosciences, Inc.
CRBUNasdaqCIK 1619856HealthcareFiscal year ends Dec 31
Reports and events: 109 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0620:07 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-415559 |
| 2026-08-1320:11 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001619856-26-000055 |
| 2026-08-1320:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001619856-26-000053 |
| 2026-06-1820:02 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001619856-26-000047 |
| 2026-06-1112:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001619856-26-000043 |
| 2026-05-0720:14 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001619856-26-000036 |
| 2026-05-0720:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001619856-26-000035 |
| 2026-04-2420:01 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001619856-26-000022 |
| 2026-03-3112:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001619856-26-000012 |
| 2026-03-0521:09 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001619856-26-000008 |
| 2026-03-0521:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001619856-26-000007 |
| 2025-11-1221:09 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001619856-25-000071 |
| 2025-11-1221:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001619856-25-000070 |
| 2025-11-0312:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001619856-25-000065 |
| 2025-08-1220:09 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001619856-25-000061 |
| 2025-08-1220:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001619856-25-000060 |
| 2025-06-2312:02 ET | 8-K | 8.01 Other events | 0001619856-25-000052 |
| 2025-06-1320:02 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001619856-25-000047 |
| 2025-05-0820:19 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001619856-25-000043 |
| 2025-05-0820:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001619856-25-000040 |
| 2025-04-2520:40 ET | SCHEDULE 13D | Ownership report, active investor | 0000950170-25-058810 |
| 2025-04-2520:02 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001619856-25-000031 |
| 2025-04-2420:17 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0001619856-25-000023 |
| 2025-03-1020:09 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001619856-25-000015 |
| 2025-03-1020:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001619856-25-000014 |
| 2025-01-1313:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001619856-25-000006 |
| 2025-01-0213:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001619856-25-000002 |
| 2024-12-0621:06 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-272453 |
| 2024-11-0621:08 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001619856-24-000081 |
| 2024-11-0621:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001619856-24-000080 |
| 2024-09-2720:02 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001619856-24-000074 |
| 2024-09-0320:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001619856-24-000071 |
| 2024-08-1212:03 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001619856-24-000068 |
| 2024-08-0620:08 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001619856-24-000064 |
| 2024-08-0620:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001619856-24-000063 |
| 2024-07-1620:01 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001619856-24-000054 |
| 2024-06-1420:03 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001619856-24-000050 |
| 2024-06-0310:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001619856-24-000046 |
| 2024-05-0720:15 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001619856-24-000038 |
| 2024-05-0720:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001619856-24-000036 |
| 2024-04-2520:02 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0001619856-24-000026 |
| 2024-04-0420:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001619856-24-000018 |
| 2024-03-1120:25 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001619856-24-000013 |
| 2024-03-1120:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001619856-24-000012 |
| 2024-01-0813:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001619856-24-000003 |
| 2023-12-2221:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001619856-23-000138 |
| 2023-12-1221:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001619856-23-000134 |
| 2023-11-1721:06 ET | 10-Q/A | Quarterly report, amendedPeriod 2023-06-30 | 0001619856-23-000130 |
| 2023-11-1721:05 ET | 10-Q/A | Quarterly report, amendedPeriod 2023-03-31 | 0001619856-23-000129 |
| 2023-11-0721:03 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001619856-23-000124 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.